University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 1 of 15
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
NCT07392580
Fasting InTervention for Endometrial Cancer
NCT07622901
Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)
NCT07502352
Self-applied taVNS for CIPN
NCT07596030
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
NCT06412120
Haptics in Virtual Reality
NCT07209228
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy
NCT07594015
Relationship Enhancement Digital Game
NCT07170553
Doxycycline Use in Post-Operative Seromas
NCT07498010
Implementing Depression and Adherence Treatment
NCT07032363
Project Independence
NCT07572110
Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury
NCT07109804
Prehabilitation Protocol for Head and Neck Cancer Patients
NCT07318220
Ventilation and Perfusion in Asthmatics
NCT07426458
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
NCT07446777
Food Intake and Thermogenesis in High Spinal Cord Injury
NCT07103993
Binaural Beats for Postoperative Pain and Anxiety Reduction
NCT07437469
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
NCT07415707
Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery
NCT07401134
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
NCT07217678
Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients
NCT07359911
Methylene Blue in Total Knee Arthroplasty (TKA)
NCT07324954
Low Versus High Load Training and Parkinson's Disease
NCT07378813
Power Training Progression Methods
NCT07378826
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
NCT06919939
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
NCT06902246
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
NCT07356167
Gut-Brain Neural Coupling in Spinal Cord Injury
NCT07052344
Effects of an Exercise Program on Reaction Time and Mouse Accuracy in Recreational Video Game Players
NCT06512675
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
NCT06952790
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
NCT06997081
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
NCT06587204
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
NCT07096362
Periodization and Parkinson's Disease
NCT07141849
Power or Plyometric Training in Older Adults
NCT06821321
Preoperative Comprehensive Geriatric Assessment (CGA) and Postoperative Delirium
NCT07059585
BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
NCT07002216
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
NCT06730555
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
NCT05956821
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
NCT05630235
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
NCT06902272
Adjuvant Quisinostat in High-Risk Uveal Melanoma
NCT06932757
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
NCT06663722
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
NCT06902285
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
NCT06487507
STARLITE for Unresectable High-Grade Gliomas
NCT06428045
The Test-to-PrEP Study
NCT06927856
Florida Community-Engaged Research Alliance (FL-CEAL)
NCT06829485
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
NCT06774079
Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
NCT06784323
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Miami pipeline card: 721 registered trials from official public datasets.Report a data error.